| Common Name | REGN 1500, evinacumab-dgnb |
|---|---|
| Synonyms | ANL3; ANG-5; FHBL2; ANGPT5 |
| Applications | ELISA |
| Recommended Dilutions | ELISA 1:5000-10000 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Homo sapiens |
| IgG type | IgG4 |
| Reactivity | Human |
| Target | |
| Uniprot ID | Q9Y5C1 |
| Description | Anti-ANGPTL3(evinacumab biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-ANGPTL3(evinacumab biosimilar) mAb
Price: 50 μg $82.00 ; 100 μg $162.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 2 μg/mL (100 μL/well) Human ANGPTL3 Protein, His Tag (PME100527) can bind Anti-ANGPTL3(evinacumab biosimilar) mAb (BME100203) in a linear range of 3.20–400 ng/mL.